Your browser doesn't support javascript.
loading
Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients.
Gordon, Jonathan A R; Evans, Mark F; Ghule, Prachi N; Lee, Kyra; Vacek, Pamela; Sprague, Brian L; Weaver, Donald L; Stein, Gary S; Stein, Janet L.
Afiliación
  • Gordon JAR; Department of Biochemistry, Larner College of Medicine at the University of Vermont, Burlington, VT, United States of America.
  • Evans MF; Department of Pathology and Laboratory Medicine, Larner College of Medicine at the University of Vermont, Burlington, VT, United States of America.
  • Ghule PN; Department of Biochemistry, Larner College of Medicine at the University of Vermont, Burlington, VT, United States of America.
  • Lee K; Department of Biochemistry, Larner College of Medicine at the University of Vermont, Burlington, VT, United States of America.
  • Vacek P; Department of Surgery, Larner College of Medicine at the University of Vermont, Burlington, VT, United States of America.
  • Sprague BL; Department of Surgery, Larner College of Medicine at the University of Vermont, Burlington, VT, United States of America.
  • Weaver DL; Department of Pathology and Laboratory Medicine, Larner College of Medicine at the University of Vermont, Burlington, VT, United States of America.
  • Stein GS; Department of Biochemistry, Larner College of Medicine at the University of Vermont, Burlington, VT, United States of America.
  • Stein JL; Department of Biochemistry, Larner College of Medicine at the University of Vermont, Burlington, VT, United States of America.
PLoS One ; 18(3): e0282473, 2023.
Article en En | MEDLINE | ID: mdl-36940196
ABSTRACT
The tumor microenvironment is a complex mixture of cell types that bi-directionally interact and influence tumor initiation, progression, recurrence, and patient survival. Mesenchymal stromal cells (MSCs) of the tumor microenvironment engage in crosstalk with cancer cells to mediate epigenetic control of gene expression. We identified CD90+ MSCs residing in the tumor microenvironment of patients with invasive breast cancer that exhibit a unique gene expression signature. Single-cell transcriptional analysis of these MSCs in tumor-associated stroma identified a distinct subpopulation characterized by increased expression of genes functionally related to extracellular matrix signaling. Blocking the TGFß pathway reveals that these cells directly contribute to cancer cell proliferation. Our findings provide novel insight into communication between breast cancer cells and MSCs that are consistent with an epithelial to mesenchymal transition and acquisition of competency for compromised control of proliferation, mobility, motility, and phenotype.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Células Madre Mesenquimatosas Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Células Madre Mesenquimatosas Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
...